+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Angina Pectoris Drugs Market Report 2026 - Product Thumbnail Image

Angina Pectoris Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Xenotransplantation Market Report 2026 - Product Thumbnail Image

Xenotransplantation Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
Cardiometabolic Diseases Market Report 2026 - Product Thumbnail Image

Cardiometabolic Diseases Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Small Molecule Drug Conjugates Market - Global Forecast 2026-2032 - Product Thumbnail Image

Small Molecule Drug Conjugates Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 184 Pages
  • Global
From
From
Incontinence Medication Market - Global Forecast 2026-2032 - Product Thumbnail Image

Incontinence Medication Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
From
From
Anti-infectives Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anti-infectives Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
Blastomycosis Market - Global Forecast 2026-2032 - Product Thumbnail Image

Blastomycosis Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 188 Pages
  • Global
From
From
Loading Indicator